Janus Kinase Inhibitor

In this video, John M. Davis, III, MD, clinical rheumatologist and professor of medicine at Mayo Clinic College of Medicine and Science, discussed the "crowded market space" that the rheumatoid arthritis pipeline and its long-term outlook.

In this video, Carolyn Goh, MD,  clinical associate professor in dermatology at David Geffen School of Medicine at UCLA, discusses treatments in the pipeline for alopecia areata — including two additional Janus kinase inhibitors and other treatments that use different mechanisms of action — and how “it is exciting that there are so many potential medications coming” for alopecia areata.